(Reuters) – The effectiveness of the Pfizer Inc/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when deciding on the need for booster shots. Read full story
Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months -study
